These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4039615)

  • 1. Dose effects of naloxone on fixed morphine dependence: simultaneous behavioral and 2-deoxyglucose study in the rat.
    Geary WA; Wooten GF
    Brain Res; 1985 Apr; 332(1):69-78. PubMed ID: 4039615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time action profiles of regional cerebral glucose utilization during naloxone-precipitated morphine withdrawal.
    Geary WA; Wooten GF
    Brain Res; 1986 Dec; 399(1):181-4. PubMed ID: 3801919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence and withdrawal following intracerebroventricular and systemic morphine administration: functional anatomy and behavior.
    Adams RE; Wooten GF
    Brain Res; 1990 Jun; 518(1-2):6-10. PubMed ID: 2390728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is morphine dependence mediated exclusively by the Mu receptor?
    Adams RE; Wooten GF
    Neurochem Res; 1993 Oct; 18(10):1041-5. PubMed ID: 8255352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration.
    Adams RE; Wooten GF
    Neurochem Res; 1994 Oct; 19(10):1243-8. PubMed ID: 7891840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral glucose utilization during morphine withdrawal in the rat.
    Wooten GF; DiStefano P; Collins RC
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3360-4. PubMed ID: 6954484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysis.
    Le Guen S; Gestreau C; Besson JM
    J Comp Neurol; 2001 Apr; 433(2):272-96. PubMed ID: 11283964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine withdrawal syndrome: differential participation of structures located within the amygdaloid complex and striatum of the rat.
    Calvino B; Lagowska J; Ben-Ari Y
    Brain Res; 1979 Nov; 177(1):19-34. PubMed ID: 574050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
    Maldonado R; Stinus L; Gold LH; Koob GF
    J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A behavioral and 2-deoxyglucose autoradiographic study of the effects of cumulative morphine dose on naloxone precipitated withdrawal in the rat.
    Geary WA; Wooten GF
    Brain Res; 1983 Sep; 275(1):117-26. PubMed ID: 6684966
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
    Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
    Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice.
    Wen D; Zhao P; Hui R; Wang J; Shen Q; Gong M; Guo H; Cong B; Ma C
    Neuropharmacology; 2017 May; 118():199-208. PubMed ID: 28359771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical correlates of morphine-withdrawal syndrome: differential participation of structures located within the limbic system and striatum.
    Tremblay EC; Charton G
    Neurosci Lett; 1981 May; 23(2):137-42. PubMed ID: 7196001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does morphine withdrawal produce brain damage in rats?
    Turski WA; Czuczwar SJ; Kleinrok Z; Turski L
    Life Sci; 1983; 33 Suppl 1():397-400. PubMed ID: 6686636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats.
    Marshall DC; Buccafusco JJ
    Brain Res; 1985 Mar; 329(1-2):131-42. PubMed ID: 4038893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo tracer studies of glucose metabolism, cerebral blood flow, and protein synthesis in naloxone precipitated morphine withdrawal.
    Geary WA; Wooten GF
    Neurochem Res; 1987 Jul; 12(7):573-80. PubMed ID: 3614509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla.
    Bederson JB; Fields HL; Barbaro NM
    Somatosens Mot Res; 1990; 7(2):185-203. PubMed ID: 2378192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Budziszewska B; Jaworska-Feil L; LasoĊ„ W
    Eur Neuropsychopharmacol; 1996 May; 6(2):135-40. PubMed ID: 8791039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.